Alanosine
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
JSmol) | |
| |
| |
(verify) |
Alanosine (also called SDX-102)[1] is a substance that has been studied for the treatment of pancreatic cancer.[2] It is an antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.[needs update]
References
- ^ PubChem. "Alanosine". pubchem.ncbi.nlm.nih.gov. Retrieved 2021-04-08.
- PMID 11763167.